Orthocell (ASX:OCC) Share Price and News - StockTrack

Market Cap (19-Sep) $202,456,464 (943rd)	Close (30-Jun) $0.350 0 (0%)	Volume (30-Jun) 313,271	Shortsold (26-May) 1,281,555 (0.47%) (313th)
52w High $1.60	52w Low $0.70	P/E -	EPS -0.05

	Subject
	OCC OCC Ann: Ortho-ATI Shoulder Tendon Study Update Revised
	1 (current) 2 3
	OCC OCC Ann: Ortho-ATI Shoulder Tendon Study Update
	OCC OCC Ann: Appendix 4E and Annual Report to Shareholders
	OCC OCC Ann: Appendix 4G
	OCC OCC Ann: Annual General Meeting
	OCC OCC Ann: CelGro Nerve Study Results Presented at AOA annual Meeting
	OCC OCC Ann: Notice under Section 708(A) of the Corporations Act
	OCC OCC Ann: Application for quotation of securities - OCC
	OCC OCC Ann: Notice under Section 708(A) of the Corporations Act
	OCC OCC Ann: Application for quotation of securities - OCC
	OCC OCC Ann: CelGro Facilitates Lymphatic Vessel Regeneration Updated
	OCC OCC Ann: CelGro Facilitates Lymphatic Vessel Regeneration
	OCC OCC Ann: Appendix 4C - Quarterly
	OCC OCC Ann: Orthocell Appoints Exclusive Distributor in Australia
	OCC OCC Ann: Notice under Section 708(A) of the Corporations Act
	OCC OCC Ann: Application for quotation of securities - OCC
	OCC OCC Ann: Application for quotation of securities - OCC
	OCC OCC Ann: Application for quotation of securities - OCC
	OCC OCC Ann: Positive CelGro Nerve Regeneration Results
	OCC OCC Ann: OCC Secures Patents for Sutureless Repair of Soft Tissue
	OCC OCC Ann: Proposed issue of Securities - OCC
	OCC OCC Ann: New Collagen Rope Patent for CelGro Platform Technology
	OCC OCC Ann: Appendix 2A and Notice Under Section 708A
	OCC OCC Ann: Appendix 4C - Quarterly
	OCC OCC Ann: CelGro Study Results Open Up New US Market Access Strategy
	OCC OCC Ann: Change of Director's Interest Notice LL
	OCC OCC Ann: Appendix 2A and Notice Under Section 708A
	OCC OCC Ann: CelGro gains Australian reimbursement
	OCC OCC Ann: Half Yearly Report and Accounts
	OCC OCC Ann: Appendix 2A and Notice Under Section 708A
	OCC OCC Ann: Orthocell receives new US patent for CelGro
	OCC OCC Ann: Proposed issue of Securities - OCC
	OCC OCC Ann: Ceasing to be a substantial holder
	OCC OCC Ann: CelGro Recommended for Reimbursement
	OCC OCC Ann: Appendix 4C - Quarterly
	OCC OCC Ann: Change of Director's Interest Notice * 5
	OCC OCC Ann: Novel Surgical Treatment for Tendon Repair
	OCC OCC Ann: Appendix 2A
	OCC OCC Ann: Orthocell Receives A$2.3m R&D Tax Incentive Refund
	OCC OCC Ann: Orthocell Receives First US CelGro Product Approval
	OCC OCC Ann: Trading Halt
	OCC OCC Ann: Pause in Trading
	OCC OCC Ann: Appendix 2A and Notice Under Section 708A
	OCC OCC Ann: CelGro Receives Australian Market Approval
	OCC OCC Ann: CelGro Completes Pivotal Step in TGA Approval Process
	OCC OCC Ann: Change of Director's Interest Notice * 4
	OCC OCC Ann: Positive Results in CelGro Nerve Repair Study
	OCC OCC Ann: Trading Halt
	OCC OCC Ann: Appendix 4C - Quarterly
	OCC OCC Ann: Appendix 3G

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$1.12	758,292	0.00 (0.00%)
12-Sep	$1.12	247,148	+0.01 (0.90%)
11-Sep	$1.11	330,575	-0.02 (1.77%)
05-Sep	$1.13	511,112	-0.01 (0.44%)
04-Sep	$1.14	476,108	+0.01 (0.44%)
03-Sep	$1.13	514,610	-0.07 (5.44%)
29-Aug	$1.20	532,915	0.00 (0.42%)
28-Aug	$1.20	335,340	-0.01 (0.83%)
22-Aug	$1.21	267,667	+0.01 (1.26%)
21-Aug	$1.20	409,886	-0.14 (10.15%)
15-Aug	$1.33	701,428	+0.07 (5.56%)
14-Aug	$1.26	688,516	0.00 (0.00%)
07-Aug	$1.26	596,297	-0.01 (1.18%)
31-Jul	$1.28	268,083	-0.02 (1.54%)
30-Jul	$1.30	238,931	-0.02 (1.15%)
4 up, 9 down, and 2 flat days

High $0.35	Low $0.32	Trades 32	Turnover $102,945	Volume 313,271
30 June 2023 at 4:10pm

High $0.35	Low $0.32	Trades 32	Turnover $102,945	Volume 313,271
30 June 2023 at 4:10pm

Orthocell Health Care

$0.350 0.020 (6.06%)

$0.350 0.020 (6.06%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices